Associated Papers
Schedule-dependent synergistic interaction between docetaxel and gefitinib in NSCLC cell lines regardless of the mutation status of EGFR and KRAS and its molecular mechanisms.
Jiang Y et al.
Journal of Cancer Research and Clinical Oncology, 2014
Select a paper to view details